Kazuo Kobayashi

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Pharmacogenomic profiling of the efficacy of gemcitabine monotherapy in metastatic pancreatic cancer: Subgroup analysis of the GENESECT study.

Pharmacogenomic profiling of the efficacy of gemcitabine monotherapy in metastatic pancreatic cancer: Subgroup analysis of the GENESECT study.

Journal: British journal of clinical pharmacology

Published: January 27, 2026

Factors Associated With Nonadherence to S-1 in Docetaxel+S-1(DS) Therapy, an Adjuvant Treatment for Gastric Cancer.

Factors Associated With Nonadherence to S-1 in Docetaxel+S-1(DS) Therapy, an Adjuvant Treatment for Gastric Cancer.

Journal: Anticancer research

Published: January 23, 2026

Antiemetic Efficacy of Dexamethasone Omission in Antiemetic Therapy During Highly Emetogenic Chemotherapy for Breast Cancer.

Antiemetic Efficacy of Dexamethasone Omission in Antiemetic Therapy During Highly Emetogenic Chemotherapy for Breast Cancer.

Journal: Die Pharmazie

Published: November 11, 2025

Usefulness of pharmacy outpatient clinic follow-up for maintaining relative dose intensity in patients on adjuvant CAPOX chemotherapy for gastric cancer.

Usefulness of pharmacy outpatient clinic follow-up for maintaining relative dose intensity in patients on adjuvant CAPOX chemotherapy for gastric cancer.

Journal: Molecular and clinical oncology

Published: July 09, 2025

Early Higher Plasma Regorafenib Concentration Predicts Shorter PFS in Japanese Patients With mCRC.

Early Higher Plasma Regorafenib Concentration Predicts Shorter PFS in Japanese Patients With mCRC.

Journal: Clinical and translational science

Published: April 04, 2025

Age-Stratified Risk of Carboplatin-Induced Nausea and Vomiting in Lung Cancer Patients.

Age-Stratified Risk of Carboplatin-Induced Nausea and Vomiting in Lung Cancer Patients.

Journal: Oncology

Published: December 01, 2024

Investigation of the Changes in Blood Cell Components following the Administration of Pegfilgrastim in Neo-Adjuvant and Adjuvant FEC Chemotherapy for Breast Cancer

Investigation of the Changes in Blood Cell Components following the Administration of Pegfilgrastim in Neo-Adjuvant and Adjuvant FEC Chemotherapy for Breast Cancer

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: October 27, 2024

Cost of Pegfilgrastim for the Prophylaxis of Chemotherapy-induced Febrile Neutropenia in Patients with Breast Cancer Receiving Perioperative Chemotherapy in Daily Practice in Japan: A Posthoc Analysis in a Single-center Retrospective Study.

Cost of Pegfilgrastim for the Prophylaxis of Chemotherapy-induced Febrile Neutropenia in Patients with Breast Cancer Receiving Perioperative Chemotherapy in Daily Practice in Japan: A Posthoc Analysis in a Single-center Retrospective Study.

Journal: Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan

Published: September 01, 2024

Analysis of Adverse Events Associated with Trastuzumab Deruxtecan in Patients with Gastric and Breast Cancer: A Retrospective Study.

Analysis of Adverse Events Associated with Trastuzumab Deruxtecan in Patients with Gastric and Breast Cancer: A Retrospective Study.

Journal: Biological & pharmaceutical bulletin

Published: February 12, 2024

Evaluation of the Leftover Capecitabine Tablets in Adjuvant CAPOX Chemotherapy for Gastric Cancer

Evaluation of the Leftover Capecitabine Tablets in Adjuvant CAPOX Chemotherapy for Gastric Cancer

Journal: Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan

Published: December 03, 2023

Influence of menopause on chemotherapy-induced nausea and vomiting in highly emetogenic chemotherapy for breast cancer: A retrospective observational study.

Influence of menopause on chemotherapy-induced nausea and vomiting in highly emetogenic chemotherapy for breast cancer: A retrospective observational study.

Journal: Cancer medicine

Published: February 03, 2023

Factors associated with lenvatinib adherence in thyroid cancer and hepatocellular carcinoma.

Factors associated with lenvatinib adherence in thyroid cancer and hepatocellular carcinoma.

Journal: PloS one

Published: January 16, 2023

Showing 1-12 of 25

Last Updated: 09/26/2026